世界の抗肥満薬市場2020-2027:作用機序別(末梢作用薬、中枢作用薬)、薬剤種類別、地域別

◆英語タイトル:Global Anti-obesity Drugs Market Size study, by Mechanism of Action (Peripherally Acting Drugs, and Centrally Acting Drugs), by Drug Type (Prescription Drugs, and OTC Drugs)and Regional Forecasts 2020-2027
◆商品コード:BZW21AP066
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月15日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の抗肥満薬市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、作用機序別(末梢作用薬、中枢作用薬)分析、薬剤種類別(処方薬、OTC薬)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の抗肥満薬市場規模:作用機序別(末梢作用薬、中枢作用薬)
・世界の抗肥満薬市場規模:薬剤種類別(処方薬、OTC薬)
・世界の抗肥満薬市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Anti-obesity Drugs Market is valued approximately USD 1.39 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 15% over the forecast period 2020-2027. Anti-obesity medications help decrease body fat by either decreasing appetite or rising calorie intake. The increases in number of obese patients worldwide are predicted to be exacerbated by the consumption of fast foods coupled with lack of exercise. The intake of unhealthy fast foods, and rising disposable income, fuel consumer demand for anti-obesity therapeutics. Advanced medical research has also contributed significantly to the development of the anti-obesity medicines through drug-producing firms, medical colleges and institutes, and government agencies. For Instance: According to Trust for America’s health, In 2020,The U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country’s obesity crisis. The national adult obesity rate has increased by 26 percent since 2008. However, high costsimpedes the growth of the market over the forecast period of 2020-2027. Also, changing eating habits and rising consumption of fast foods will lead to the adoption & demand for Anti-Obesity Drugs.

The regional analysis of global Anti-obesity Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increase in the obese population and high healthcare spending. Whereas,Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income and rising population would create lucrative growth prospects for the Anti-obesity Drugs market across Asia-Pacific region.

Major market player included in this report are:
Boehringer Ingelheim GmbH
Arena Pharmaceuticals Inc.
Takeda Pharmaceuticals Company Limited
Zydus Cadila
Rhythm Pharmaceuticals
Merck & Co. Inc.
Eisai Co. Ltd.
Novo Nordisk A/S
Orexigen Therapeutics Inc.
GlaxoSmithKline PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Mechanism of Action:
Peripherally Acting Drugs
Centrally Acting Drugs

By Drug Type:
Prescription Drugs
OTC Drugs

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Anti-obesity Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Anti-obesity Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Anti-obesity Drugs Market, by Mechanism of action,2018-2027 (USD Billion)
1.2.3. Anti-obesity Drugs Market, by Drug type,2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anti-obesity Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anti-obesity Drugs Market Dynamics
3.1. Anti-obesity Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anti-obesity Drugs MarketIndustry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-obesity Drugs Market, by Mechanism of action
5.1. Market Snapshot
5.2. Global Anti-obesity Drugs Market by Mechanism of action, Performance – Potential Analysis
5.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Mechanism of action2017-2027 (USD Billion)
5.4. Anti-obesity Drugs Market, Sub Segment Analysis
5.4.1. Peripherally Acting Drugs
5.4.2. Centrally Acting Drugs
Chapter 6. Global Anti-obesity Drugs Market, by Drug type
6.1. Market Snapshot
6.2. Global Anti-obesity Drugs Market by Drug type, Performance – Potential Analysis
6.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Drug type2017-2027 (USD Billion)
6.4. Anti-obesity Drugs Market, Sub Segment Analysis
6.4.1. Prescription Drugs
6.4.2. OTC Drugs
Chapter 7. Global Anti-obesity Drugs Market, Regional Analysis
7.1. Anti-obesity Drugs Market, Regional Market Snapshot
7.2. North America Anti-obesity Drugs Market
7.2.1. U.S.Anti-obesity Drugs Market
7.2.1.1. Mechanism of actionbreakdown estimates & forecasts, 2017-2027
7.2.1.2. Drug typebreakdown estimates & forecasts, 2017-2027
7.2.2. CanadaAnti-obesity Drugs Market
7.3. Europe Anti-obesity Drugs Market Snapshot
7.3.1. U.K. Anti-obesity Drugs Market
7.3.2. Germany Anti-obesity Drugs Market
7.3.3. France Anti-obesity Drugs Market
7.3.4. Spain Anti-obesity Drugs Market
7.3.5. Italy Anti-obesity Drugs Market
7.3.6. Rest of EuropeAnti-obesity Drugs Market
7.4. Asia-PacificAnti-obesity Drugs Market Snapshot
7.4.1. China Anti-obesity Drugs Market
7.4.2. India Anti-obesity Drugs Market
7.4.3. JapanAnti-obesity Drugs Market
7.4.4. Australia Anti-obesity Drugs Market
7.4.5. South Korea Anti-obesity Drugs Market
7.4.6. Rest of Asia PacificAnti-obesity Drugs Market
7.5. Latin America Anti-obesity Drugs Market Snapshot
7.5.1. Brazil Anti-obesity Drugs Market
7.5.2. Mexico Anti-obesity Drugs Market
7.6. Rest of The World Anti-obesity Drugs Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim GmbH

8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Arena Pharmaceuticals Inc.
8.2.3. Takeda Pharmaceuticals Company Limited
8.2.4. Zydus Cadila
8.2.5. Rhythm Pharmaceuticals
8.2.6. Merck & Co. Inc.
8.2.7. Eisai Co. Ltd.
8.2.8. Novo Nordisk A/S
8.2.9. Orexigen Therapeutics Inc.
8.2.10. GlaxoSmithKline PLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Anti-obesity Drugs market, report scope
TABLE 2. Global Anti-obesity Drugs market estimates & forecasts by Region 2017-2027 (USDBillion)
TABLE 3. Global Anti-obesity Drugs market estimates & forecasts byMechanism of action2017-2027 (USDBillion)
TABLE 4. Global Anti-obesity Drugs market estimates & forecasts byDrug type2017-2027 (USDBillion)
TABLE 5. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 6. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 7. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 8. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 9. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 10. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 11. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 12. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 13. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 14. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
TABLE 15. U.S. Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 16. U.S. Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 17. U.S. Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 18. Canada Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 19. Canada Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 20. Canada Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 21. UKAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 22. UKAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 23. UKAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 24. Germany Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 25. Germany Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 26. Germany Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 27. RoEAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 28. RoEAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 29. RoEAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 30. China Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 31. China Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 32. China Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 33. India Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 34. India Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 35. India Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 36. Japan Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 37. Japan Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 38. Japan Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 39. RoAPACAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 40. RoAPACAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 41. RoAPACAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 42. Brazil Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 43. Brazil Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 44. Brazil Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 45. Mexico Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 46. Mexico Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 47. Mexico Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 48. RoLAAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 49. RoLAAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 50. RoLAAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 51. Row Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
TABLE 52. Row Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 53. Row Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
TABLE 54. List of secondary sources, used in the study of global Anti-obesity Drugs market
TABLE 55. List of primary sources, used in the study of global Anti-obesity Drugs market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

List of figures
FIG 1. Global Anti-obesity Drugs market, research methodology
FIG 2. Global Anti-obesity Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Anti-obesity Drugs market, key trends 2019
FIG 5. Global Anti-obesity Drugs market, growth prospects 2020-2027
FIG 6. Global Anti-obesity Drugs market, porters 5 force model
FIG 7. Global Anti-obesity Drugs market, pest analysis
FIG 8. Global Anti-obesity Drugs market, value chain analysis
FIG 9. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
FIG 10. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
FIG 11. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
FIG 12. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
FIG 13. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
FIG 14. Global Anti-obesity Drugs market, regional snapshot 2017 & 2027
FIG 15. North America Anti-obesity Drugs market2017 & 2027 (USDBillion)
FIG 16. Europe Anti-obesity Drugs market2017 & 2027 (USDBillion)
FIG 17. Asia pacific Anti-obesity Drugs market2017 & 2027 (USDBillion)
FIG 18. Latin America Anti-obesity Drugs market2017 & 2027 (USDBillion)
FIG 19. Global Anti-obesity Drugs market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の抗肥満薬市場2020-2027:作用機序別(末梢作用薬、中枢作用薬)、薬剤種類別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆